COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,627 Articles (22,913 medRxiv, 8,714 bioRxiv)

Most recent first Previous |  Page 1624: Articles 16231-16240  | Next

Efficacy of universal masking for source control and personal protection from simulated cough and exhaled aerosols in a room
Lindsley, W. G., Beezhold, D. H., Derk, R. C., Coyle, J., Blachere, F. M., Boots, T., Reynolds, J. S., McKinney, W. G., Sinsel, E., Noti, J. D.
10.1101/2021.04.21.21255880 — Posted: 2021-04-25
Effects of the COVID-19 Pandemic on Park Use in U.S. Cities
Jay, J., Heykoop, F., Hwang, L., de Jong, J., Kondo, M.
10.1101/2021.04.23.21256007 — Posted: 2021-04-25
COVID-19 Vaccine Hesitancy among the Adult Population in Bangladesh: A Nationally Representative Cross-sectional Survey
Hossain, M. B., Alam, M. Z., Islam, M. S., Sultan, S., Faysal, M. M., Rima, S., Hossain, M. A., Mamun, A. A.
10.1101/2021.04.23.21255844 — Posted: 2021-04-25
Epidemiology of COVID-19 and effect of public health interventions, Chennai, India, March - October 2020
Murugesan, J., Ganeshkumar, P., Kaur, P., Masanam Sriramulu, H., Sakthivel, M., Rubeshkumar, P., Raju, M., Murugesan, L., Ganapathi, R., Srinivasan, M., Sukumar, A., Ilangovan, K., Madhusudhan, R., Shanmugam, D., Govindasamy, P., Murhekar, M.
10.1101/2021.04.21.21255852 — Posted: 2021-04-25
A systematic review on Multisystem Inflammatory Syndrome in Children (MIS-C) with COVID-19: Development of a scoring system for clinical diagnosis
Surve, D. S. V., Joseph, M. S., Gajbhiye, D. R. K., Mahale, S. D., Modi, D. D. N.
10.1101/2021.04.23.21255879 — Posted: 2021-04-25
Maternal and child outcomes reported by breastfeeding women following mRNA COVID-19 vaccination
Bertrand, K., Honerkamp-Smith, G., Chambers, C. D.
10.1101/2021.04.21.21255841 — Posted: 2021-04-25
Impact of national and regional lockdowns on COVID-19 epidemic waves: Application to the 2020 spring wave in France
Roux, J., Massonnaud, C., Colizza, V., Cauchemez, S., Crepey, P.
10.1101/2021.04.21.21255876 — Posted: 2021-04-25
Optimal health and economic impact of non-pharmaceutical intervention measures prior and post vaccination in England: a mathematical modelling study
Tildesley, M., Vassall, A., Riley, S., Jit, M., Sandmann, F., Hill, E. M., Thompson, R., Atkins, B., Edmunds, J., Dyson, L. M., Keeling, M. J.
10.1101/2021.04.22.21255949 — Posted: 2021-04-25
Exploring the Behavioral Determinants of COVID-19 Vaccine Acceptance among an Urban Population in Bangladesh: Implications for Behavior Change Interventions
Kalam, M. A., Davis, T. P., Shano, S., Uddin, N., Islam, M. A., Kanwagi, R., Islam, A., Hassan, M. M., Larson, H. J.
10.1101/2021.04.23.21255974 — Posted: 2021-04-25
Risk Profile of Thanksgiving Gatherers and Subsequent SARS-CoV2 Testing and Diagnosis
You, W., Rane, M. S., Zimba, R., Berry, A., Kulkarni, S. G., Westmoreland, D. A., Parcesepe, A., Chang, M., Maroko, A. R., Kochhar, S., Mirzayi, C., Grov, C., Nash, D.
10.1101/2021.04.22.21255631 — Posted: 2021-04-25

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).